Today

Agents

Chat

Arena

Discover

More

App

Ovid Therapeutics Q2 EPS USD -0.08 - OVID News | Rallies

Ovid Therapeutics Q2 EPS USD -0.08

OVID•2026-08-13

Q2 financial results

Aug. 13 (Reuters) - Ovid Therapeutics Q2 net income was USD -15.009 million.

Q2 operating expenses: USD 16.431 million
Q2 revenue: USD 733 thousand vs. IBES estimate USD 0

Related News

RenX Q2 FY26 net loss narrows to $8.02 million; revenue rises 7.5% Q/Q to $4.26 million

RENX•2026-08-13

CareCredit survey shows Americans overlook chiropractic care in long-term wellness routines, Synchrony says

SYF•2026-08-13

Kontoor Brands, Inc. <KTB.N>: UBS raises target price to $136 from $131

KTB

•

2026-08-13

LIVE MARKETS-S&P 500 futures edge up, yields ease after tame PPI reading

SPY•2026-08-13

Avalanche Treasury schedules conference call for Q2 2026 results

AVAT•2026-08-13